WisPaper
WisPaper
Search
Assistant
Pricing
TrueCite

Does statin therapy cause significant muscle pain?

Statins cause a small increase in muscle pain, but most muscle symptoms reported by patients are not actually caused by the statin.

Direct answer

Yes, statin therapy does cause a small increase in muscle pain, but the risk is much lower than many people believe. The largest and most definitive study on this question — a 2022 meta-analysis of 23 double-blind, randomized trials involving over 123,000 participants — found that statins caused only a 7% relative increase in muscle pain or weakness during the first year of treatment. This means that for every 100 people taking a statin, only about 1 extra person will experience muscle pain because of the drug; the other 99 reports of muscle pain would have happened anyway. After the first year, there was no significant difference in muscle pain between statin and placebo groups. Across all the studies reviewed here, the larger trials consistently show that while statins can cause muscle symptoms, the vast majority of muscle complaints in people taking statins are not due to the medication itself [1][9].

10sources cited

This article was generated with WisPaper-powered search and paper analysis.

How big is the risk of muscle pain from statins?

The risk is small. The most authoritative evidence comes from a 2022 individual participant data meta-analysis of 19 placebo-controlled trials (123,940 participants) and 4 trials comparing different statin intensities (30,724 participants). During the first year, statins caused a 7% relative increase in muscle pain or weakness — which translates to an absolute excess rate of just 11 extra cases per 1,000 person-years. In plain terms, only about 1 in 15 reports of muscle pain from someone taking a statin is actually caused by the drug; the other 14 would have occurred even if they were taking a placebo [1][9]. After the first year, there was no significant excess of muscle pain at all [1].

A separate prospective study of 250 patients newly started on atorvastatin or rosuvastatin found that 16% developed muscle symptoms, but the vast majority were mild and self-limited, resolving within 2 weeks of stopping the drug. Importantly, 73% of these cases occurred within the first 3 months of therapy [4]. This aligns with the meta-analysis finding that the risk is highest early on.

High-intensity statins (e.g., atorvastatin 40–80 mg or rosuvastatin 20–40 mg daily) carry a slightly higher risk than moderate-intensity regimens. The meta-analysis found a rate ratio of 1.08 for high-intensity versus 1.03 for moderate-intensity compared to placebo [1]. A study of 418 acute coronary syndrome patients on high-intensity statins found that only 19 (4.5%) developed muscle symptoms using a validated clinical scoring system [5].

Why do so many people blame statins for muscle pain if the risk is small?

Because muscle pain is extremely common in the general population, especially as people age. The meta-analysis found that 26.6% of people in the placebo group reported muscle pain or weakness — meaning over a quarter of people who were not taking any statin at all still had muscle symptoms [1]. When someone taking a statin develops muscle pain, it is natural to suspect the drug, but the data show that in most cases the pain would have occurred anyway. This is called the 'nocebo effect' — people experience side effects because they expect them.

A 2026 analysis of over 5,300 Reddit discussions about statins found that adverse effects were the most common topic (31.9% of posts), and muscle pain was the most frequently mentioned specific symptom (7.6% of adverse effect mentions) [2]. This highlights how much attention muscle pain gets in public discourse, which can amplify perceptions of risk beyond what the evidence supports.

Interestingly, genetic factors may play a role for a small subset of people. A 2019 study identified a common genetic variant in the LILRB5 gene that was associated with a 34% increased odds of statin intolerance across multiple studies, including the large JUPITER trial [7]. This suggests that for a minority of patients, there is a genuine biological susceptibility to statin-induced muscle pain.

What should you do if you have muscle pain while taking a statin?

First, do not stop the medication on your own. The cardiovascular benefits of statins — preventing heart attacks, strokes, and deaths — are far larger than the small risk of muscle pain [1]. Instead, talk to your doctor. There are several evidence-based strategies that can help.

One approach is to use a validated tool like the Statin Myalgia Clinical Index (SMCI) to assess whether the pain is likely caused by the statin. A 2022 study in Korean patients found that while 7% reported new muscle pain on atorvastatin, only 3.4% were classified as 'possible' or 'probable' statin-related by the SMCI [8]. This tool helps distinguish true statin-induced myalgia from coincidental muscle pain.

If the pain is likely statin-related, options include: (1) reducing the dose or switching to a lower-intensity statin — a study found that lowering from high to moderate intensity resolved symptoms in most patients [5]; (2) trying a different statin — a case report showed successful switching to pitavastatin combined with ezetimibe resolved muscle symptoms while maintaining cholesterol control [10]; (3) checking for other causes like vitamin D deficiency or thyroid problems [4]. Coenzyme Q10 supplements, despite popular belief, do not help — a meta-analysis of 7 randomized trials found no benefit over placebo for muscle pain or statin adherence [6].

Importantly, routine creatine kinase (CK) monitoring is not recommended for all patients, but it can be useful if symptoms develop. A study found that elevated CK after starting a statin was the only independent predictor of statin-associated muscle symptoms (odds ratio 2.85) [4]. However, most cases of statin-induced myalgia occur with normal CK levels [3].

About These Sources

This answer is built on 10 peer-reviewed studies — published from 2019 to 2026, 4 from 2024 or later, 5 in Q1 journals, collectively cited 215 times — selected as the most relevant from 12 studies that passed quality screening, drawn from 53 papers retrieved from a database of over 500 million.

Sources used in this answer

1

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

In the largest and most definitive study here — an individual participant data meta-analysis of 19 placebo-controlled trials (123,940 participants) and 4 intensive-vs-less-intensive trials (30,724 participants) — statins caused a 7% relative increase in muscle pain or weakness during year 1 (absolute excess 11 per 1,000 person-years), but no significant excess after year 1; over 90% of muscle reports were not due to the statin.

2

Large Language Model-Based Analysis of Statin Therapy Discussions and Sentiment on Social Media: Cross-Sectional Observational Study.

An analysis of 5,328 Reddit posts about statins found that adverse effects were the most discussed topic (31.9%), with muscle pain mentioned in 7.6% of adverse effect posts; overall sentiment was negative in 30.9% of discussions, highlighting public concern that may exceed actual risk.

3

Plasma statin concentrations do not correlate with statin-induced myalgia

Across three case-control studies (373 patients total), plasma concentrations of statin metabolites were not higher in patients with myalgia compared to controls; in fact, two studies found lower concentrations in affected patients, indicating that myalgia is not caused by pharmacokinetic abnormalities.

4

Musculoskeletal Disorders in Patients on Statin Therapy: Prospective and Observational Study at a Tertiary Care Hospital

In a prospective study of 250 patients newly started on atorvastatin or rosuvastatin, 16% developed musculoskeletal symptoms (92.7% myalgia), mostly within 3 months and self-limited; elevated post-statin creatine kinase was the only independent predictor (OR 2.85).

5

Statin induced myalgia on high intensity statin in patients with Acute Coronary Syndrome

In 418 acute coronary syndrome patients on high-intensity statins, only 19 (4.5%) developed muscle symptoms by the Statin Myalgia Clinical Index; dose reduction to moderate intensity resolved symptoms in most cases.

6

Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis.

A meta-analysis of 7 randomized controlled trials (321 patients) found no benefit of coenzyme Q10 supplementation over placebo for statin-associated myalgia (weighted mean difference -0.42) or for improving statin adherence (RR 0.99).

7

A common missense variant of LILRB5 is associated with statin intolerance and myalgia.

A genetic variant in LILRB5 (Asp247) was associated with statin intolerance across multiple studies (meta-analysis OR 1.34), including the JUPITER trial (OR 1.35 for myalgia), suggesting a genetic subgroup with true susceptibility.

8

A Prospective Single-Center Study of Incidence of Atorvastatin-Induced Myalgia in Korean Patients: Application of the Statin Myalgia Clinical Index

In 89 Korean patients on atorvastatin, 7% reported new muscle pain, but only 3.4% were classified as 'possible' or 'probable' statin-related by the Statin Myalgia Clinical Index, showing the tool's value in distinguishing true from coincidental myalgia.

9

Statins: Most muscle pains reported by patients are not caused by statins, study finds

A BMJ news article summarizing the 2022 meta-analysis [1] reports that statins caused a 7% relative increase in muscle pain during year 1, with no significant difference after year 1.

10

Management of a patient at very high cardiovascular risk with myositis during high-intensity statin therapy

A case report of a 56-year-old patient with very high cardiovascular risk who developed myositis on high-intensity statin; switching to pitavastatin 2 mg plus ezetimibe 10 mg resolved muscle symptoms while achieving LDL cholesterol targets.